5-amino-1mq full name Peptide 5-Amino-1MQ - CAS 42464-96-0 -

Cyanocobalamin injection

How 5-Amino-1MQ May Affect NNMT and Metabolism 5-Amino-1MQ is commonly discussed because it may inhibit nicotinamide N-methyltransferase, also known as NNMT

Standard Dosing Ranges The most extensively studied dosing protocols for subcutaneous administration include: Research-Based Dosing Protocols Beginner/Conservative Protocol: Dose: 250-300 mcg once daily Duration: 4-8 weeks initial assessment period Rationale: Allows tolerance assessment and response evaluation at lower end of therapeutic range Standard Protocol: Dose: 300-500 mcg once daily Duration: 12-24 weeks based on clinical trials Rationale: Most commonly studied range in human research with optimal benefit-to-safety ratio Advanced Protocol: Dose: 500 mcg-1 mg once daily Duration: 12-24 weeks under close medical monitoring Rationale: Upper clinical range

Note: Because AOD-9604 does not affect glucose metabolism or IGF-1, monitoring requirements are simpler than with growth hormone therapy